Research Grade Zamerovimab

Catalog No.

DVV03904

Expression system

Mammalian Cells

Species reactivity

Rabies virus (RABV)

Host species

Humanized

Isotype

IgG1, kappa

Clonality

Monoclonal

Applications

Research Grade Biosimilar

Target

G, Glycoprotein

Concentration

4.5 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

O92284, P08667

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

CTB 011, CTB-011, CTB011, SYN023 CAS: 2419087-87-7

Clone ID

Zamerovimab

Note

For research use only. Not suitable for clinical or therapeutic use.

The efficacy and safety of SYN023 (Zamerovimab and Mazorelvimab injection), the recombinant humanized anti-rabies virus monoclonal antibody mixture, combined with rabies vaccine in a WHO category III rabies post-exposure population: A randomized, double-blind, positive control, phase III clinical trial., PMID:40479926

Document Download

Research Grade Zamerovimab.pdf